lilly glp 1 pill Ground News | Federal regulators approved Eli Lilly's new weight-loss pill, orforglipron, giving patients a second daily oral GLP-1 treatment for obesity FDA approves Lilly's Foundayo (orforglipron)

Support your GLP1 journey with portioncontrolled meals that are proteinforward and calorieconscious

Discover what the evidence says about berberine, fibre, omega-3, and other natural compounds, plus important safety advice and when to see your GP.

Its time that we change the way we treat type 2 diabetes

Understanding your baseline lipid profile, genetic predispositions, and metabolic biomarkers helps guide informed conversations with healthcare providers about realistic outcomes and personalized treatment goals

Coverage restrictions and high out-of-pocket costs

As eating patterns become more consistent and hydration habits improve, many patients notice a steadier rhythm to their skin and overall energy